NIBSC develops new-CE marked virus triplex for NAT PCR blood testing – HBC, HCV, HIV

 

Having trouble viewing this email? View it as a Web page.

 

NIBSC Logo

Dear colleague

The following news item has been added to the NIBSC website:

NIBSC develops new-CE marked virus triplex for NAT PCR blood testing – HBC, HCV, HIV

NIBSC are pleased to announce the availability of a very low positive triplex reagent (NIBSC Code 14/198) for NAT assays containing hepatitis B (HBV), hepatitis C (HCV) and human immunodeficiency virus-1 (HIV-1).

Medicines and healthcare products Regulatory Agency